$1.43 Billion is the total value of Cormorant Asset Management, LP's 73 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 26.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $116,790,000 | +103.9% | 1,979,158 | -2.5% | 8.16% | +88.5% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $100,947,000 | +135.0% | 1,478,000 | +55.6% | 7.06% | +117.2% |
| DSGN | Sell | DESIGN THERAPEUTICS INC | $83,600,000 | +8.6% | 5,000,000 | -9.1% | 5.84% | +0.4% |
| ERASCA INC | $81,943,000 | +40.0% | 10,505,554 | 0.0% | 5.73% | +29.5% | ||
| Buy | ARCELLX INC | $57,233,000 | +107.6% | 3,049,173 | +99.9% | 4.00% | +91.8% | |
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $47,064,000 | +52.4% | 6,065,001 | 0.0% | 3.29% | +40.9% | ||
| ALT | Buy | ALTIMMUNE INC | $43,965,000 | +25.3% | 3,442,863 | +14.8% | 3.07% | +15.8% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $40,158,000 | +99.4% | 575,000 | +91.7% | 2.81% | +84.3% |
| RVMD | REVOLUTION MEDICINES INC | $39,343,000 | +1.2% | 1,995,066 | 0.0% | 2.75% | -6.5% | |
| AVTE | Buy | AEROVATE THERAPEUTICS INC | $38,643,000 | +42.9% | 2,330,691 | +34.7% | 2.70% | +32.1% |
| GOSS | Buy | GOSSAMER BIO INC | $38,317,000 | +2208.3% | 3,198,382 | +1512.2% | 2.68% | +2025.4% |
| TARS | Buy | TARSUS PHARMACEUTICALS INC | $33,751,000 | +23.3% | 1,971,422 | +5.1% | 2.36% | +14.0% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $33,740,000 | +113.4% | 150,000 | +20.0% | 2.36% | +97.2% |
| RNA | AVIDITY BIOSCIENCES INC | $32,858,000 | +12.4% | 2,012,115 | 0.0% | 2.30% | +3.9% | |
| IMMUNEERING CORP | $32,738,000 | +164.7% | 2,286,181 | 0.0% | 2.29% | +144.7% | ||
| BMEA | BIOMEA FUSION INC | $31,011,000 | -18.4% | 3,170,872 | 0.0% | 2.17% | -24.5% | |
| EWTX | Sell | EDGEWISE THERAPEUTICS INC | $30,032,000 | -2.0% | 3,051,989 | -20.7% | 2.10% | -9.4% |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $27,950,000 | +3.7% | 184,894 | 0.0% | 1.95% | -4.1% | |
| Buy | VENTYX BIOSCIENCES INC | $27,252,000 | +185.5% | 780,646 | +0.0% | 1.90% | +163.9% | |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $26,868,000 | +164.6% | 1,310,000 | +49.3% | 1.88% | +144.5% |
| GLUE | MONTE ROSA THERAPEUTICS INC | $24,459,000 | -15.5% | 2,993,717 | 0.0% | 1.71% | -21.9% | |
| Buy | GREENLIGHT BIOSCIENCS HLDS P | $23,807,000 | +56.3% | 10,261,560 | +47.4% | 1.66% | +44.4% | |
| AXNX | AXONICS INC | $22,699,000 | +24.3% | 322,240 | 0.0% | 1.59% | +14.9% | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $22,108,000 | – | 200,000 | +100.0% | 1.54% | – |
| COGT | Buy | COGENT BIOSCIENCES INC | $21,634,000 | +219.8% | 1,450,000 | +93.3% | 1.51% | +195.3% |
| VERV | Sell | VERVE THERAPEUTICS INC | $20,610,000 | +92.5% | 600,000 | -14.4% | 1.44% | +77.9% |
| ACET | Sell | ADICET BIO INC | $19,908,000 | -24.2% | 1,400,000 | -22.2% | 1.39% | -30.0% |
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $19,110,000 | – | 1,000,000 | +100.0% | 1.34% | – |
| New | AMYLYX PHARMACEUTICALS INC | $17,172,000 | – | 610,000 | +100.0% | 1.20% | – | |
| BCAB | Buy | BIOATLA INC | $16,795,000 | +189.1% | 2,181,115 | +7.0% | 1.17% | +167.4% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $16,352,000 | +323.2% | 782,788 | +62.3% | 1.14% | +291.4% |
| VECT | Sell | VECTIVBIO HLDG AG | $15,220,000 | -0.8% | 2,536,617 | -10.7% | 1.06% | -8.3% |
| Sell | TANGO THERAPEUTICS INC | $14,903,000 | -27.0% | 4,116,949 | -8.7% | 1.04% | -32.5% | |
| BBIO | BRIDGEBIO PHARMA INC | $14,604,000 | +9.5% | 1,469,179 | 0.0% | 1.02% | +1.2% | |
| CYTK | Sell | CYTOKINETICS INC | $14,341,000 | -8.7% | 296,000 | -26.0% | 1.00% | -15.7% |
| STOK | STOKE THERAPEUTICS INC | $13,967,000 | -2.8% | 1,087,807 | 0.0% | 0.98% | -10.2% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $13,862,000 | +16.0% | 868,550 | 0.0% | 0.97% | +7.2% | |
| RAIN | RAIN THERAPEUTICS INC | $11,354,000 | -12.2% | 2,326,660 | 0.0% | 0.79% | -18.8% | |
| Buy | ASTRIA THERAPEUTICS INC | $10,848,000 | +1105.3% | 1,200,000 | +300.0% | 0.76% | +1014.7% | |
| LLY | New | LILLY ELI & CO | $9,701,000 | – | 30,000 | +100.0% | 0.68% | – |
| PHVS | Buy | PHARVARIS N V | $9,262,000 | -63.4% | 1,207,500 | +5.4% | 0.65% | -66.2% |
| ISEE | New | IVERIC BIO INCput | $8,970,000 | – | 500,000 | +100.0% | 0.63% | – |
| AVIR | ATEA PHARMACEUTICALS INC | $8,803,000 | -19.9% | 1,547,181 | 0.0% | 0.62% | -26.0% | |
| CNTA | Sell | CENTESSA PHARMACEUTICALS PLCsponsored ads | $7,930,000 | -44.4% | 1,972,728 | -32.6% | 0.55% | -48.6% |
| LBPH | Sell | LONGBOARD PHARMACEUTICALS IN | $7,880,000 | +12.2% | 2,118,283 | -6.8% | 0.55% | +3.8% |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $6,891,000 | +13.5% | 593,043 | -2.5% | 0.48% | +5.0% |
| ALXO | ALX ONCOLOGY HLDGS INC | $6,815,000 | +18.3% | 712,079 | 0.0% | 0.48% | +9.2% | |
| TYRA BIOSCIENCES INC | $6,540,000 | +22.9% | 743,988 | 0.0% | 0.46% | +13.7% | ||
| PSTX | New | POSEIDA THERAPEUTICS INC | $6,531,000 | – | 1,850,000 | +100.0% | 0.46% | – |
| IDYA | New | IDEAYA BIOSCIENCES INC | $6,241,000 | – | 418,320 | +100.0% | 0.44% | – |
| OLMA | OLEMA PHARMACEUTICALS INC | $5,746,000 | -32.2% | 2,082,000 | 0.0% | 0.40% | -37.3% | |
| VIGIL NEUROSCIENCE INC | $5,613,000 | +252.8% | 616,786 | 0.0% | 0.39% | +226.7% | ||
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $5,163,000 | +11.1% | 50,000 | 0.0% | 0.36% | +2.8% | |
| KROS | KEROS THERAPEUTICS INC | $3,762,000 | +36.2% | 100,000 | 0.0% | 0.26% | +25.8% | |
| ELDN | Sell | ELEDON PHARMACEUTICALS INC | $3,377,000 | +6.1% | 1,223,500 | -6.3% | 0.24% | -2.1% |
| AKUS | AKOUOS INC | $2,667,000 | +44.2% | 394,500 | 0.0% | 0.19% | +32.9% | |
| AMAM | Sell | AMBRX BIOPHARMA INCsponsored ads | $2,523,000 | -61.7% | 2,336,389 | -6.0% | 0.18% | -64.7% |
| TALS | Sell | TALARIS THERAPEUTICS INC | $2,369,000 | -55.3% | 900,649 | -23.3% | 0.17% | -58.6% |
| ELEV | Sell | ELEVATION ONCOLOGY INC | $2,206,000 | -20.5% | 1,952,032 | -1.6% | 0.15% | -26.7% |
| YMAB | Y-MABS THERAPEUTICS INC | $2,163,000 | -4.7% | 150,000 | 0.0% | 0.15% | -12.2% | |
| Sell | ICOSAVAX INC | $2,034,000 | -45.5% | 643,825 | -1.2% | 0.14% | -49.6% | |
| GLTO | GALECTO INC | $1,928,000 | +9.2% | 1,020,238 | 0.0% | 0.14% | +1.5% | |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $1,420,000 | +1320.0% | 830,654 | +698.9% | 0.10% | +1137.5% |
| Buy | PYXIS ONCOLOGY INC | $1,318,000 | -17.2% | 668,855 | +0.0% | 0.09% | -23.3% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $839,000 | -24.4% | 392,167 | 0.0% | 0.06% | -29.8% | |
| CABA | CABALETTA BIO INC | $750,000 | -38.7% | 1,154,424 | 0.0% | 0.05% | -44.1% | |
| CMMB | Buy | CHEMOMAB THERAPEUTICS LTDsponsored ads | $718,000 | -32.6% | 288,169 | +0.0% | 0.05% | -38.3% |
| Sell | GELESIS HLDGS INC | $676,000 | -30.3% | 626,107 | -0.0% | 0.05% | -35.6% | |
| GRPH | GRAPHITE BIO INC | $633,000 | +15.3% | 199,547 | 0.0% | 0.04% | +4.8% | |
| HARP | HARPOON THERAPEUTICS INC | $524,000 | -49.3% | 540,600 | 0.0% | 0.04% | -52.6% | |
| BCEL | ATRECA INC | $501,000 | -12.3% | 319,057 | 0.0% | 0.04% | -18.6% | |
| IMV | IMV INC | $122,000 | -21.3% | 234,374 | 0.0% | 0.01% | -25.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCspon ads | $128,000 | -14.7% | 256,649 | 0.0% | 0.01% | -18.2% | |
| Exit | RENOVACOR INC | $0 | – | -500,000 | -100.0% | -0.08% | – | |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
| MGTX | Exit | MEIRAGTX HLDGS PLC | $0 | – | -150,000 | -100.0% | -0.09% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -403,787 | -100.0% | -0.29% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -200,000 | -100.0% | -0.41% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -205,000 | -100.0% | -0.59% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -1,200,000 | -100.0% | -0.75% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -475,000 | -100.0% | -0.88% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -275,000 | -100.0% | -1.19% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -267,500 | -100.0% | -1.61% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -3,172,204 | -100.0% | -1.65% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -450,000 | -100.0% | -2.53% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -1,425,000 | -100.0% | -2.67% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -2,484,220 | -100.0% | -14.14% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.